Table 10 Cost effectiveness analysis (US Dollars)
| Â | Argentina | Brazil | Chile | Colombia | Mexico | Peru |
|---|---|---|---|---|---|---|
Main analysis | Â | Â | Â | Â | Â | Â |
ICER - QALYs gained | $ 3,347.53 | $ 7,088.64 | $ -230.13 | $ 4,021.37 | $ 4,594.33 | $ 2,975.23 |
ICER - Life years gained | $ 14,136.50 | $ 8,057.94 | $ -3,799.67 | $ 8,336.48 | $ 5,774.23 | $ 6,401.33 |
3xGDP per capita threshold | $ 22,277 | $ 24,884 | $ 27,021 | $ 14,966 | $ 30,598 | $ 13,129 |
Secondary analysis | Â | Â | Â | Â | Â | Â |
ICER - QALYs gained | Â | Â | Â | Â | Â | Â |
Base case + indirect costs | $ 1,509.59 | $ 4,810.99 | $ -2,133.38 | $ 2,433.32 | $ 3,243.41 | $ 1,535.87 |
Base case + herd immunity | $ 3,295.13 | $ 6,293.05 | -235.11 | $ 3,885.80 | $ 4,144.01 | $ 2,920.73 |
Base case + indirect effect + herd immunity | $ 1,454.51 | $ 4,024.69 | -2,141.37 | $ 2,295.77 | $ 2,790.71 | $ 1,478.95 |
ICER - Life years gained | Â | Â | Â | Â | Â | Â |
Base case + indirect costs | $ 6,374.94 | $ 5,468.84 | $ -35,223.99 | $ 5,044.38 | $ 4,076.37 | $ 3,304.48 |
Base case + herd immunity | $ 13,439.35 | $ 7,092.43 | -3,511.26 | $ 7,928.28 | $ 5,059.29 | $ 6,186.27 |
Base case + indirect effect + herd immunity | $ 5,932.31 | $ 4,535.93 | -31,980.90 | $ 4,684.11 | $ 3,307.09 | $ 3,132.50 |